Show
Sort by
-
Inhibitors targeting RIPK1/RIPK3 : old and new drugs
-
- Journal Article
- A1
- open access
RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
-
Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy
-
Tozasertib analogues as inhibitors of necroptotic cell death
-
- Journal Article
- A1
- open access
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury
-
Novel ferroptosis inhibitors with improved potency and ADME properties